Low-dosage mitomycin C as an adjunct to trabeculectomy. A prospective controlled study

European Journal of Ophthalmology

Volumn 7, Issue 1, 1997, Pages 40-48

  Martini, E ^a,b   Laffi, G L ^a   Sprovieri, C ^a   Scorolli, L ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Antimetabolites; Mitomycin C; Open angle glaucoma; Trabeculectomy

Indexed keywords

MITOMYCIN C;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR HYPOTENSION; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCAR FORMATION; TOPICAL DRUG ADMINISTRATION; TRABECULECTOMY;

EID: 0030974563     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067219700700108     Document Type: Article

References (49)

1. Anderson DR. Giaucoma: the damage caused by pressure. Jackson Memorial Lecture. Am J Ophthalmol 1989; 108: 485-95.
2. Palmberg PF. The rationale and effectiveness of glaucoma therapy. Am Glaucoma Society, Miami (Fl), Dic. 1988.
3. Odberg T. Visual field prognosis in advanced glaucoma. Acta Ophthalmol 1987; 65 (suppl 182): S27-S29.
4. Hitchings RA, Migdal CS, Fitzke F. Intraocular pressure control: does it protect the visual field? In: Krieglstein GK, ed. Glaucoma update IV. Berlin: Springer Verlag 1991 ; 179-86.
5. Abedin S, Simmons RJ, Grant WM. Progressive low tension glaucoma. Treatment to stop glaucomatous cupping and visual field loss when these progress despite normal IOP. Ophthalmology 1982; 89: 1-6.
6. Kolker AE. Visual prognosis in advanced glaucoma: a comparison of medical and surgical therapy for retention of vision in 101 eyes with advanced glaucoma. Trans Am Ophthalmol Soc 1977; 75: 539-55.
7. Quigley HA, Maumenee AE. Long-term follow-up of treated open-angle glaucoma. Am J Ophthalmol 1979; 87: 519-25.
8. Palmberg PF. Glaucoma surgery with mitomycin: a review. Chibret lnt J Ophthalmol 1994; 10: 16-21.
9. Hitchings RA. The best option for POAG: medicine or surgery. Chibret lnt J Ophthalmol 1994; 10: 86-91.
10. Papovic V, Sjostrand J. Long-term outcome following trabeculectomy. Acta Ophthalmol 1991; 69: 299-304.
11. Migdal C, Gregory W, Hitchings RA. Long-term functional outcome after early surgery compared with laser and medicine in open angle glaucoma. Ophthalmology 1994; 101: 1651-7.
12. Werner EB, Drance SM, Schulzer M. Trabeculectomy and the progression of glaucomatous visual field loss. Arch Ophthalmol 1977; 95: 1374-7.
13. Dake CL, Greve EL. Four-year follow-up of glaucoma operation, lnt Ophthalmol 1979; 1: 139-45.
14. Costa VP. Primary trabeculectomy in young adults. Ophthalmology 1993; 100: 1071-6
15. Migdal C, Hitchings RA. Control of chronic simple glaucoma with primary medical, surgical and laser treatment. Trans Ophthalmol Soc UK 1986; 105: 653-6.
16. Jay IL, Murray SB. Early trabeculectomy vs. conventional management in primary open-angle glaucoma. Br J Ophthalmol 1988; 72: 881-9.
17. Watson PG, Jakeman C, Ozturk M, et al. The complications of trabeculectomy (a 20 years follow-up). Eye 1990; 4: 425-38.
18. Sturmer J, Broadway DC, Hitchings RA. Young patient trabeculectomy. Assessment of risk factors for failure. Ophthalmology 1993; 100: 928-39.
19. David R, Freedman T, Luntz A. A comparative study of Watson's and Cairn's trabeculectomies in a black population with open angle glaucoma. Br J Ophthalmol 1977; 61: 117-9.
20. D'Ermo F, Bonomi L, Doro D. A critical analysis of the long-term results of trabeculectomy. Am J Ophthalmol 1979; 88: 829-35.
21. Inaba A. Long-term results of trabeculectomy in the Japanese: an analysis by the life-table method. Jpn J Ophthalmol 1982; 26: 361-72.
22. Watson PG, Grierson I. The place of trabeculectomy in the treatment of glaucoma. Ophthalmology 1981; 88: 175-96.
23. Wilson P. Trabeculectomy: long-term follow-up. Br J Ophthalmol 1977; 61: 535-8.
24. Rollins DF, Drance SM. Five-year follow-up of trabeculectomy in the management of chronic angle glaucoma. In: ″Symposium on glaucoma″. Trans of the New Orleans Academy of Ophthalmology. St Louis: CV Mosby 1981; 295-307.
25. Schwartz AL, Anderson DR, Trabecular surgery. Arch Ophthalmol 1974; 92: 134-8.
26. Addicks EM, Quigley HA, Green WR, Robin AL. Histologic characteristics of filtering blebs in glaucomatous eyes. Arch Ophthalmol 1983; 101: 795-8.
27. Skuta GL, Parrish RK II, Wound healing in glaucoma filtration surgery. Surv Ophthalmol 1987; 32: 149-70.
28. Desjardins DC, Parrish RK II, Folberg R, et al. Wound healing after filtering surgery in owl monkey. Arch Ophthalmol 1986; 104: 1835-9.
29. Jampel HD, McGuigan LJB, Dunkelberger GR, et al. Cellular proliferation after experimental glaucoma filtration surgery. Arch Ophthalmol 1988; 106: 89-94.
30. Parrish RK II, Folberg R. Wound healing in glaucoma surgery. In: Ritch R, Shields MB, Krupin T, eds. The glaucomas. St. Louis: CV Mosby 1989; 633-43.
31. Khaw PT, Doyle JW, Sherwood MP, et al. Effect of intraoperative 5FU or mitomycin C on glaucoma filtration surgery in the rabbit. Ophthalmology 1993; 100: 367-72.
32. Tahery MD, Lee DA. Review: pharmacologic control wound healing in glaucoma filtering surgery. J Ocul Pharmacol 1989; 5: 155-79.
33. Parrish RK II. Antiproliferative surgery: intraoperative mitomycin C versus postoperative 5-fluorouracil. Chibret lnt J Ophthalmol 1994; 10/3: 76-85.
34. Heuer DK, Parrish RK II, Gressel MQ, et al. 5-fluorouracil and glaucoma findings surgery. II - A pilot study. Ophthalmology 1984; 91: 384-94.
35. Kersten H. Mechanisms of action of mitomycins. In: Antineoplastic and immunosuppressive agents; pt. II. In: Sartorelli AC, Johns DG, eds. Handbuch der Experimentellen Pharmakologic. Vol 38 - Berlin: Springer Verlag 1975; 47-64.
36. Yamamoto T, Varani J, Soong H, et al. Effects of 5FU and mitomycin C on cultured rabbit subconjunctival fibroblasts. Ophthalmology 1990; 97: 1204-10.
37. Chen CW. Enhanced intraocular pressure controlling effectiveness of trabeculectomy by local application of Mitomycin C. Trans Asia-Pacific Acad Ophthalmol 1983; 9: 172-7.
38. Kitazawa Y. Low-dose and high-dose mitomycin trabeculectomy as an initial surgery in primary open angle glaucoma. Ophthalmology 1993; 100: 1624-8.
39. Palmer SS. Mitomycin as an adjunct chemotherapy with trabeculectomy. Ophthalmology 1991; 98: 317-21.
40. Yamamoto T, Suemori-Matsushita H, lchian M, et al. Glaucoma filtering surgery and mitomycin C. Chibret lnt J Ophthalmol 1994; 10/3: 92-6.
41. Skuta GL. Intraoperative mitomycin versus postoperative 5 fluorouracil in high-risk glaucoma filtering surgery. Ophthalmology 1992; 99: 438-44.
42. Kitazawa Y. Trabeculectomy with mitomycin: a comparative study with fluorouracil. Arch Ophthalmol 1991 ; 109: 1693-8.
43. Lamping KA, Belkin JK. 5-fluorouracil and mitomycin C in pseudophakic patients. Ophthalmology 1995; 102: 70-5.
44. Martini E, Laffi GL, Scorolli L, Meduri R. Gli antimetaboliti nella chirurgia filtrante del glaucoma: vantaggi, complicazioni, indicazioni. Bollettino di Oculistica 1996; 75 (suppl 2): S235-S248.
45. Kitazawa Y, Yamamoto T. The risk profile of mitomycin C in glaucoma surgery. Curr Opin Ophthalmol 1994; 5: 105-9.
46. Stamper RL, McMenemy MC, Lieberman MF. Hypotonus maculopathy after trabeculectomy with subconjunctival 5-fluorouracil. Am J Ophthalmol 1992; 114: 544-53.
47. Jampel HD, Pasquale JR, Dibernardo C. Hypotony maculopathy following trabeculectomy with mitomycin C. Arch Ophthalmol 1992; 110: 1049-50.
48. Yaldo MK, Stamper RL. Long-term effects of Mitomycin on filtering blebs: lack of fibrovascular proliferative response following severe inflammation. Arch Ophthalmol 1993; 111: 824-6.
49. Schwartz AL, Weiss HS. Bleb leak with hypotony after laser suture lysis and trabeculectomy with mitomicyn C. Arch Ophthalmol 1992; 110: 1046-9.